IsoRay

IsoRay Net Tangible Assets

Delisted

The Net Tangible Assets of IsoRay (ISR) as of Nov 4, 2026 is 61.17 M USD. In the previous year, Net Tangible Assets was 67.28 M USD — a change of -9.08% (lower).

Net Tangible Assets

61.17 MUSD

YoY

-9.08%

Last updated:

Net Tangible Assets of IsoRay is 2022 61.17 M USD. Net Tangible Assets of IsoRay was 2021 67.28 M USD. It decreases by -9.08% lower compared to the previous year.

The IsoRay Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2015
20.54 M USD
Jan 1, 2016
16.25 M USD
Jan 1, 2017
10.37 M USD
Jan 1, 2018
4.83 M USD
Jan 1, 2019
7.52 M USD
Jan 1, 2020
5.59 M USD
Jan 1, 2021
67.28 M USD
Jan 1, 2022
61.17 M USD
The IsoRay Net Tangible Assets history
YEARNet Tangible AssetsYoY
61.17 MUSD-9.08%
67.28 MUSD+1,104.58%
5.59 MUSD-25.71%
7.52 MUSD+55.59%
4.83 MUSD-53.41%
10.37 MUSD-36.17%
16.25 MUSD-20.87%
20.54 MUSD-13.33%
23.70 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IsoRay Stock analysis

What does IsoRay do? The company IsoRay Inc is a leading global company in the field of brachytherapy and specializes in the development of novel medical devices for the treatment of cancer. The company's history dates back to the 1980s when it was founded by a team of doctors and scientists. IsoRay Inc's business model is based on the research, development, and manufacturing of medical products used in the treatment of cancer. Brachytherapy is a particularly important focus. This involves a treatment method where radioactive seeds or sources are directly implanted into the tumor. The radiation destroys the cancer cells without damaging the surrounding tissue. IsoRay Inc's product range includes a variety of medical devices and accessories for conducting brachytherapy procedures. The company specializes in the development of high-tech products that enable precise and effective radiation therapy. This includes, for example, radioactive seeds that are directly implanted into the tumor or apparatuses that can selectively use radiation in specific structures of the body. A special focus of IsoRay Inc is computer-assisted planning of brachytherapy treatments. The tumor is precisely measured and the radiation sources are individually customized based on the data to achieve an optimal radiation dose. This planning is done using modern software and is an important factor for the successful treatment of cancer. In addition to research and development of medical products, IsoRay Inc also encompasses the production and distribution of these products. The company operates in more than 30 countries worldwide and collaborates closely with numerous clinics and practices to research and improve new technologies in the field of radiation therapy. One of IsoRay Inc's most well-known products is the "Cesium-131 Brachytherapy seed." This radioactive seed is particularly small and therefore ideal for targeted radiation therapy of tumors. It is used in almost all clinical areas worldwide and is considered particularly safe and effective. Other products of the company include the "Gladius™ Applicator Needle," a device for precise placement of radiation sources in tumors, as well as "Intraoperative Application Systems" that enable effective radiation therapy during surgery. Overall, IsoRay Inc is considered an innovative and successful company in the field of brachytherapy and radiation therapy. The constant development and improvement of its own products is a key factor for the company's success. High quality and close collaboration with research and practice are central to its operations. IsoRay is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IsoRay stock

Net Tangible Assets of IsoRay is 61.17 M USD in 2022.

Net Tangible Assets of IsoRay changed from 67.28 M USD to 61.17 M USD, representing a -9.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets IsoRay since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's IsoRay historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — IsoRay

All Key Metrics — IsoRay